G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $87,733 | -7.1% | 35,234 | 0.0% | 0.01% | -16.7% |
Q1 2023 | $94,428 | -50.6% | 35,234 | 0.0% | 0.01% | -50.0% |
Q4 2022 | $191,321 | -56.5% | 35,234 | 0.0% | 0.02% | -58.6% |
Q3 2022 | $440,000 | +152.9% | 35,234 | 0.0% | 0.06% | +176.2% |
Q2 2022 | $174,000 | -35.1% | 35,234 | 0.0% | 0.02% | -27.6% |
Q1 2022 | $268,000 | -25.6% | 35,234 | 0.0% | 0.03% | -23.7% |
Q4 2021 | $360,000 | -23.9% | 35,234 | 0.0% | 0.04% | -26.9% |
Q3 2021 | $473,000 | -38.8% | 35,234 | 0.0% | 0.05% | -39.5% |
Q2 2021 | $773,000 | -8.8% | 35,234 | 0.0% | 0.09% | -14.0% |
Q1 2021 | $848,000 | +33.8% | 35,234 | 0.0% | 0.10% | +12.4% |
Q4 2020 | $634,000 | +55.8% | 35,234 | 0.0% | 0.09% | +34.8% |
Q3 2020 | $407,000 | -52.4% | 35,234 | 0.0% | 0.07% | -56.0% |
Q2 2020 | $855,000 | +120.4% | 35,234 | 0.0% | 0.15% | +92.3% |
Q1 2020 | $388,000 | -58.3% | 35,234 | 0.0% | 0.08% | -67.5% |
Q4 2019 | $931,000 | +15.9% | 35,234 | 0.0% | 0.24% | +16.5% |
Q3 2019 | $803,000 | -25.6% | 35,234 | 0.0% | 0.21% | -29.9% |
Q2 2019 | $1,080,000 | +84.6% | 35,234 | 0.0% | 0.29% | +72.9% |
Q1 2019 | $585,000 | – | 35,234 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |